Trial intelligence / Profile preview

Digoxin Evaluation in Chronic Heart Failure (Dutch Outpatient Study)

2018-003789-15Phase 4Active

Sponsor
University Medical Center Groningen
Start
Jan 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in chronic heart failure (CHF) comparing Low-dose digoxin with Placebo (2 arms). Primary endpoint: Composite of repeated heart failure hospitalizations and cardiovascular death. Started Jan 2019; status: active.

02

Drugs

digoxin
03

Conditions

chronic heart failure (CHF)

Beyond the preview

Go deeper on 2018-003789-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-003789-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call